John Mee’s purpose is to improve millions of lives by creating a CRISPR manufacturing enterprise with one million square feet of factory space. He is accustomed to managing manufacturing businesses of this scale, having directed product development in one of Honeywell’s divisions. The technicians in Honeywell’s clean rooms were making microchips, not biologics, but at the executive level, the management processes are the same.

Dean Radin, PhD, is Chief Scientist at the Institute of Noetic Sciences (IONS) and Associated Distinguished Professor at the California Institute of Integral Studies. He earned an MS in electrical engineering and a PhD in psychology from the University of Illinois. He is author of four popular books: The Conscious Universe (1997), Entangled Minds (2006), Supernormal (2013), and Real Magic (2018)

Barry J. Linder, MD, is a seasoned medical technology executive, physician business leader, and entrepreneur. He has over 30 years of management and operational experience in executive leadership positions in privately financed growth and commercial stage medical device companies, as well as senior positions across multiple divisions within a large, integrated, healthcare delivery network.

Mr. Hitt holds BS degrees in Physics and Business and Public Administration from the University of Texas and a JD from Southern Methodist University. He has practiced intellectual property law for 30 years, gaining extensive experience in patent procurement and counseling in a wide array of physical, electrical, mechanical, mathematical, and computer technologies.

James H. Fallon, Ph.D. is Professor of Psychiatry and Human Behavior at the University of California, Irvine. He holds a Sloan Fellowship, Senior Fulbright Fellowship and NIH Research Career Award. He was Chair of the UCI Faculty and Academic Senate and Chair of the UCI College of Medicine. He sits on numerous corporate boards and national think tanks for science, biotechnology, the arts, and the military.

Dr. Troy T. Rohn received his Ph.D. in pharmacology from the University of Washington in 1994 and completed postdoctoral research at Montana State University and the Institute for Memory Impairments and Neurological Disorders at UC Irvine. Dr. Rohn is a professor in the Department of Biological Sciences at Boise State University and his research focuses on the pathology of neurodegenerative diseases.